About 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one
4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one (PubChem CID 123171917) has the molecular formula C26H24N6O7S2
and a molecular weight of 596.65 g/mol. Its IUPAC name is 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one.
Analyze 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one?
The IUPAC name of 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one (CID 123171917) is 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one.
What is the SMILES notation for 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one?
The canonical SMILES for 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one is CS(=O)(=O)C(c1nnc(Cc2[nH]c(=O)[nH]c2O)o1)c1nc2ccc(-c3ccc(C(=O)N4CCOCC4)cc3)cc2s1.
What is the InChIKey of 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one?
The InChIKey is IVHSLJXQFQCWJJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H24N6O7S2/c1-41(36,37)21(23-31-30-20(39-23)13-18-22(33)29-26(35)28-18)24-27-17-7-6-16(12-19(17)40-24)14-2-4-15(5-3-14)25(34)32-8-10-38-11-9-32/h2-7,12,21,33H,8-11,13H2,1H3,(H2,28,29,35).
What are the key properties of 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one?
4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one has a molecular weight of 596.65 g/mol, XLogP of 2.27, 7 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 4-hydroxy-5-[[5-[methylsulfonyl-[6-[4-(morpholine-4-carbonyl)phenyl]-1,3-benzothiazol-2-yl]methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-dihydroimidazol-2-one is sourced from PubChem (CID 123171917), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).